NCT06274606

Brief Summary

The goal of this clinical trial is to figure out if 8 weeks of walking exercise before bariatric surgery improves risk factors for diabetes and other markers of health. This is important as it may help reduce complications after surgery, improve health markers and increase physical activity levels after surgery (which is an important marker of maintaining bariatric weight loss). The main question that this study is trying to answer is whether walking improves a risk factor for type 2 diabetes called insulin sensitivity (how well your body is able to use glucose). Adults planning to have bariatric surgery will be recruited from the Charlottesville VA area. Before they have their surgery, participants will be randomly assigned (like flipping a coin) to a group that participates in 8 weeks of walking on a treadmill (2-3 times a week) or a group that does their normal care before bariatric surgery. Researchers will compare the effects of walking before bariatric surgery on:

  • Insulin sensitivity (diabetes risk factor)
  • Health of blood vessels
  • Rate of complications after surgery
  • Weight
  • Body Fat
  • Fitness level

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 23, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

June 14, 2024

Status Verified

June 1, 2024

Enrollment Period

6 months

First QC Date

January 18, 2024

Last Update Submit

June 12, 2024

Conditions

Keywords

Bariatric surgeryObesityInsulin sensitivityExercise intervention

Outcome Measures

Primary Outcomes (1)

  • Insulin sensitivity

    Insulin sensitivity measured via the hyperinsulinemic-euglycemic clamp

    Change from baseline to after surgery (12 weeks)

Secondary Outcomes (19)

  • Surgical outcomes - readmission within 30 days of surgery

    within 30 days

  • Surgical outcomes - IV treatment as an outpatient

    Change from baseline to after surgery (12 weeks)

  • Surgical outcomes - emergency department visits

    Change from baseline to after surgery (12 weeks)

  • Surgical outcomes - time of surgery

    Intraoperative

  • Surgical outcomes - length of stay after surgery completion

    Change from baseline to after surgery (12 weeks)

  • +14 more secondary outcomes

Study Arms (2)

Exercise Group (EX-group)

EXPERIMENTAL

The EX-group will complete 8 weeks of supervised aerobic exercise training. The EX-group will also continue normal care with bariatric doctors and nurses along with the exercise intervention.

Other: Exercise Group

Standard Care Only Group (SC-group)

NO INTERVENTION

The SC-group will only complete the orientation visit and testing visits. The participants that are randomized to this group will continue normal care with bariatric doctors and nurses. They will participate in study assessment visits only.

Interventions

Previously sedentary adults awaiting bariatric surgery will be randomized to either an Exercise group (EX-group) or Standard care only group (SC-group) for 8 weeks. Outcome visits will occur before the exercise intervention, after the exercise intervention, and after surgery

Exercise Group (EX-group)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Considered sedentary based on self-reported inactivity of \< 2-3 x/week of MVPA within previous 3 months before enrollment.
  • Able to walk without use of assistive device, such as cane or walker for ≥ 10 minutes.
  • Surgery approved within 6-9 months of initial visit.
  • Signed approval from study physician (Dr. Catherine W. Varney; Medical PI of study) that participant is capable to participate.
  • Willingness to accept group randomization assignment.

You may not qualify if:

  • Any serious medical conditions, such as cancer; history cardiovascular disease of stroke, heart attack, or heart failure; type 1 diabetes mellitus; severe psychiatric illness (such as severe depression); kidney disease.
  • Autoimmune diseases such as lupus, multiple sclerosis, Graves' disease, or rheumatoid arthritis.
  • HIV or tuberculosis.
  • Currently taking medications that lead to significant weight loss (e.g., semaglutide; tirzepatide, etc).
  • Resting SBP \> 150 mmHg, DBP \> 100 mmHg.
  • Current pregnancy or plans to become pregnant during intervention.
  • Plans to be away from the Charlottesville, VA area for \> 1 week during intervention or plans of relocating during the intervention.
  • Any medical or health condition (e.g., musculoskeletal, orthopedic, or neurological conditions) that is contraindicated for safe exercise testing and training.
  • Previous weight-loss surgeries or revisions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia

Charlottesville, Virginia, 22902, United States

Location

MeSH Terms

Conditions

ObesityInsulin Resistance

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Randomization will be completely random and will only be known by biostatistician and study coordinator in department but not on study to retain true randomization unaffected by study team.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: In accordance with a parallel study design, 30 pre-bariatric-surgery patients will be randomized in a 1:1 ratio to either undergo 8-weeks of pre-operative standard of care or 8-weeks of pre-operative standard of care plus moderate exercise prior to undergoing bariatric-surgery. Randomization scheme: The randomization will be generated utilizing a permuted block randomization scheme in which 5 blocks of 6 treatment assignments (3 per treatment) will be generated via a computer algorithm. The 6 treatment assignments of each block will be listed in random sequential order and the treatment assignments will be assigned according to the random sequential order. The randomization will be generated by our biostatistician.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 18, 2024

First Posted

February 23, 2024

Study Start

July 1, 2024

Primary Completion

January 1, 2025

Study Completion

March 15, 2025

Last Updated

June 14, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Within 1 year of study completion
Access Criteria
Access to UVA Health portals, including UVA Health REDCap

Locations